ArticleAntioxidants (Basel, Switzerland)2022

Venetoclax-Resistant MV4-11 Leukemic Cells Activate PI3K/AKT Pathway for Metabolic Reprogramming and Redox Adaptation for Survival.

Hind A Alkhatabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.